Serina Therapeutics (SER) Research & Development (2018 - 2026)
Serina Therapeutics (SER) posted Research & Development of $3.82 million for Q2 2026, up 21.1% from $3.15 million a year earlier.
Powered by 
Analysis
Serina Therapeutics (SER) Research & Development (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Serina Therapeutics was $14.02 million, up 28.8% year-over-year; for FY2025, it was $13.16 million, up 75.9% from FY2024.
- Annual Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 28.8% (FY2020 to FY2025).
- In prior years, Serina Therapeutics' Research & Development was $7.48 million in FY2024 (+213.2%), $2.39 million in FY2023 (+133.0%), $1.03 million in FY2022 (-29.6%) and $1.46 million in FY2021 (-60.8%).
- The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q2 2018.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2023, with growth of 336.1%; the weakest was Q4 2021, with a decline of 58.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Serina Therapeutics | 29.17 Mn | -11.58 Mn | - | 3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.82 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 2.37 Mn |
| Sep 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 907,000.00 |
| Sep 30, 2023 | 603,000.00 |
| Jun 30, 2023 | 479,000.00 |
| Mar 31, 2023 | 399,000.00 |
| Dec 31, 2022 | 208,000.00 |
| Sep 30, 2022 | 162,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 396,000.00 |
| Dec 31, 2021 | 376,000.00 |
| Sep 30, 2021 | 275,000.00 |
| Jun 30, 2021 | 481,000.00 |
API Access
Serina Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();